LAUSANNE, Switzerland – Funds Will be Used to Commercialize a Fully Automated, Compact Molecular Diagnostics System Designed to Drive the Widespread Adoption of Personalized Medicine and Other Diagnostic Applications Including the Fight Against Infectious Disease Biocartis, a company developing and commercializing compact molecular diagnostic (MDx) systems designed to drive the widespread adoption of personalized medicine […]

WALTHAM, Mass.–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that its board of directors has authorized the repurchase of an additional $750 million of shares of its own common stock in the open market or in negotiated transactions. The new repurchase authorization will remain in effect through November 9, 2012. […]

SOUTH EASTON, Mass., Pressure BioSciences, Inc. (Nasdaq:PBIO – News) (“PBI” and the “Company”) today announced that it has entered into definitive agreements with certain investors for a registered direct offering of 843 Units priced at $1,000 per Unit. Each Unit consists of one share of the Company’s Series D Convertible Preferred Stock, convertible into approximately […]

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it has closed $20 million in a Series D round of equity financing. New investors include GE, BioMed Ventures and Henri Termeer, former Chairman and CEO of Genzyme Corporation. All previous venture investors […]

BERWYN, Pa., AMETEK, Inc. (NYSE: AME) today announced that its Board of Directors has increased the authorized level for repurchases of its common stock by $100 million. This increased authorization will be added to the approximately $5.5 million that remains available from an existing authorization approved by the Board of Directors in January 2010. Today’s […]

SiMPore Inc. has been awarded a phase 1 SBIR grant from the National Institutes of Health (NIH) to develop a microarray cell culture system. SiMPore will examine methods to create micro-patterned walls in order to expand SiMPore’s ultrathin membrane offerings from 4-wells, currently available in CytoVu® imaging slides, into a microarray format of 96 or […]

BILLERICA, Mass.–Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that it will exercise its right under the corresponding indenture (the “Indenture”) to redeem all of its 3.75% Convertible Senior Notes Due 2026 (the “Notes”) on December 1, 2011, at one hundred per cent (100%) of […]

WOBURN, Mass.–PathoGenetix Inc., today announced that the Company received $7.5 million in the second closing of its Series B financing to support the development and commercialization of its Genome Sequence Scanning technology for bacterial strain identification. Along with the $4 million raised in the first closing, announced August 1, 2011, the Series B round totals […]